VERDOT, a designer and manufacturer of downstream purification systems for the biopharmaceutical and gene therapy sectors, has completed a transaction to purchase 2.7 acres of land in the Biopole Clermont-Limagne Life Science Technology Park in Riom, France, which is planned to be the site of an approximately 45,000 sq.-ft. headquarters and manufacturing facility. Construction is expected to begin 1Q25.
 
The new site is anticipated to open early 2026 and will consolidate the company’s existing two facilities, create a Center of Excellence for bioprocessing manufacturing, R&D, and an applications lab. The new facility will result in the creation of approximately 50-75 new jobs in the local area. 
 
The state-of-the-art facility will utilize the latest technologies to design, fabricate and assemble bioprocessing purification solutions as well as create 150% additional manufacturing capacity for the company.
 
Charles Ruban, CEO of VERDOT said, “We are excited to begin construction of our new facility. The new VERDOT facility will add significant manufacturing capacity, allowing us to further reduce lead times for tailored and standard purification technologies to meet the growing demand of our biopharmaceutical customers worldwide. The consolidation of our existing facilities will create operational and R&D efficiencies that will enhance our engineering capabilities and fuel innovation, while further reducing our carbon footprint.”